This inventor holds 2 USPTO granted patents, plus 14 CIPO patents and 1 EPO patent. Top assignee: Warner-Lambert Company. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2006
Title: Petinka Ivanova Vlahova: Innovator in Pharmaceutical Crystallization
Introduction
Petinka Ivanova Vlahova is a notable inventor based in Lafayette, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the area of crystalline forms of compounds used for treating various health conditions. With a total of two patents to her name, her work is recognized for its potential impact on medical treatments.
Latest Patents
Vlahova's latest patents focus on novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1). These patents describe various forms, including Form V through Form XIX, characterized by their X-ray powder diffraction, solid-state NMR, and Raman spectroscopy. The methods for preparation and pharmaceutical compositions of these compounds are particularly useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.
Career Highlights
Vlahova is currently associated with Warner-Lambert Company, where she continues to innovate in her field. Her work has garnered attention for its scientific rigor and potential applications in medicine.
Collaborations
Throughout her career, Vlahova has collaborated with esteemed colleagues such as Stephen Robert Byrn and David Andrew Coates. These partnerships have contributed to the advancement of her research and the development of her patented inventions.
Conclusion
Petinka Ivanova Vlahova stands out as a pioneering inventor in the pharmaceutical industry. Her contributions to the development of crystalline forms of important compounds highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile